MedPath

To Compare Inflammatory Marker levels and Magnetic Resonance Spectroscopy Characteristics in Liver Cirrhotics with Minimal And Grade 1 Hepatic Encephalopathy

Not Applicable
Conditions
Health Condition 1: K740- Hepatic fibrosis
Registration Number
CTRI/2023/10/059338
Lead Sponsor
Govind Ballabh Pant Institute of Post Graduate Medical Education and Research, New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with evidence of cirrhosis on ultrasound, fibroscan or liver histopathology if available

Exclusion Criteria

Contraindications of MR spectroscopy including cardiac pacemaker without MRI compatibility, implanted cardioverter defibrillator, cochlear implant, claustrophobia etc.

Pregnancy

Patients with hepatic encephalopathy of Grade 2 or higher (By West Haven criteria) in the pastHistory of GI bleed in last one-month, spontaneous bacterial peritonitis (SBP) on prophylaxis or hepatorenal syndrome (HRS) and patients of acute on chronic liver failure (ACLF).

Patients who have received Lactulose, Rifaximin, LOLA, probiotics or anti-inflammatory drugs such as steroids and NSAIDs.

History of use of psychotropic drugs in last 6 weeks

Poor vision precluding neuropsychological assessment.

Patients with known neurological illness

History of TIPSS or Shunt surgery

Active ongoing infection

Hepatocellular carcinoma or severe medical problems such as congestive heart failure, pulmonary disease, or neurological or psychiatric disorder.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath